Cytosolic delivery of antisense oligonucleotides by listeriolysin O-containing liposomes

Gene Therapy

Volumn 10, Issue 13, 2003, Pages 1105-1115

  Mathew, E ^a   Hardee, G E ^b   Bennett, C F ^b   Lee, K D ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b ISIS PHARMACEUTICALS   (United States)

Author keywords

Antisense; Endosomes; Liposomes; Listeriolysin O; Macrophages; Oligonucleotides

Indexed keywords

ALICAFORSEN; ANTISENSE OLIGONUCLEOTIDE; FLUORESCENT DYE; HEMOLYSIN; INTERCELLULAR ADHESION MOLECULE 1; ISIS 3082; ISIS 8997; LIPOSOME; LISTERIOLYSIN; MESSENGER RNA; POLYNUCLEOTIDE; UNCLASSIFIED DRUG; BACTERIAL TOXIN; HEAT SHOCK PROTEIN; HLYA PROTEIN, LISTERIA MONOCYTOGENES;

ANIMAL CELL; BONE MARROW CELL; CELL CULTURE; CELL MEMBRANE PERMEABILITY; CELL TRANSPORT; CELLULAR DISTRIBUTION; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOSOL; DRUG HALF LIFE; EPIFLUORESCENCE MICROSCOPY; FLOW CYTOMETRY; GENE DELIVERY SYSTEM; GENE EXPRESSION; LISTERIA MONOCYTOGENES; MACROPHAGE; MOUSE; NONHUMAN; NORTHERN BLOTTING; PERMEABILITY BARRIER; PRIORITY JOURNAL; PROTEIN TARGETING; REVIEW; ANIMAL; ARTICLE; BAGG ALBINO MOUSE; FEMALE; FLUORESCENCE MICROSCOPY; GENE THERAPY; GENETICS; METABOLISM; METHODOLOGY;

ANIMALIA; LISTERIA; LISTERIA MONOCYTOGENES; MURINAE;

ANIMALS; BACTERIAL TOXINS; BLOTTING, NORTHERN; BONE MARROW CELLS; CELLS, CULTURED; CYTOSOL; FEMALE; FLOW CYTOMETRY; GENE THERAPY; HEAT-SHOCK PROTEINS; HEMOLYSIN PROTEINS; INTERCELLULAR ADHESION MOLECULE-1; LIPOSOMES; MICE; MICE, INBRED BALB C; MICROSCOPY, FLUORESCENCE; OLIGONUCLEOTIDES, ANTISENSE; RNA, MESSENGER;

EID: 0038601430     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3301966     Document Type: Review

References (44)

1. Crooke ST. Therapeutic applications of oligonucleotides. Annu Rev Pharmacol Toxicol 1992; 32: 329-376.
2. Mahato RI, Takakura Y, Hashida M. Development of targeted delivery systems for nucleic acid drugs. J Drug Target 1997; 4: 337-357.
3. Juliano RL et al. Antisense pharmacodynamics: critical issues in the transport and delivery of antisense oligonucleotides. Pharm Res 1999; 16: 494-502.
4. Lebedeva I, Stein C. Antisense oligonucleotides: promise and reality. Annu Rev Pharmacol Toxicol 2001; 41: 403-419.
5. Chin DJ et al. Rapid nuclear accumulation of injected oligodeoxyribonucleotides. New Biol 1990; 2: 1091-1100.
6. Leonetti JP et al. Intracellular distribution of microinjected antisense oligonucleotides. Proc Natl Acad Sci USA 1991; 88: 2702-2706.
7. Bennett CF et al. Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides. Mol Pharmacol 1992; 41: 1023-1033.
8. Nestle FO et al. Cationic lipid is not required for uptake and selective inhibitory activity of ICAM-1 phosphorothioate antisense oligonucleotides in keratinocytes. J Invest Dermatol 1994; 103: 569-575.
9. Dean NM, McKay R. Inhibition of protein kinase C-alpha expression in mice after systemic administration of phosphorothioate antisense oligodeoxynucleotides. Proc Natl Acad Sci USA 1994; 91: 11762-11766.
10. Stepkowski SM, Tu Y, Condon TP, Bennett CF. Blocking of heart allograft rejection by intercellular adhesion molecule-1 antisense oligonucleotides alone or in combination with other immunosuppressive modalities. J Immunol 1994; 153: 5336-5346.
11. Kumasaka T et al. Role of the intercellular adhesion molecule-1 (ICAM-1) in endotoxin-induced pneumonia evaluated using ICAM-1 antisense oligonucleotides, anti-ICAM-1 monoclonal antibodies and ICAM-1 mutant mice. J Clin Invest 1996; 97: 2362-2369.
12. Bennett CF et al. An ICAM-1 antisense oligonucleotide prevents and reverses dextran sulfate sodium-induced colitis in mice. J Pharmacol Exp Ther 1997; 280: 988-1000.
13. Stein CA. Controversies in the cellular pharmacology of oligodeoxynucleotides. Ciba Found Symp 1997; 209: 79-89; discussion 89-93.
14. Butler M, Stecker K, Bennett CF. Cellular distribution of phosphorothioate oligodeoxynucleotides in normal rodent tissues. Lab Invest 1997; 77: 379-388.
15. Bijsterbosch MK et al. In vivo fate of phosphorothioate antisense oligodeoxynucleotides: predominant uptake by scavenger receptors on endothelial liver cells. Nucleic Acids Res 1997; 25: 3290-3296.
16. Henry SP et al. Correlation of toxicity and pharmacokinetic properties of a phosphorothioate oligonucleotide designed to inhibit ICAM-1. Toxicol Pathol 1999; 27: 95-100.
17. Lee KD, Oh YK, Portnoy DA, Swanson JA. Delivery of macromolecules into cytosol using liposomes containing hemolysin from Listeria monocytogenes. J Biol Chem 1996; 271: 7249-7252.
18. Mandal M, Lee KD. Listeriolysin O-liposome-mediated cytosolic delivery of macromolecule antigen in vivo: enhancement of antigen-specific cytotoxic T lymphocyte frequency, activity, and tumor protection. Biochim Biophys Acta 2002; 1563: 7-17.
19. Geoffroy C, Gaillard JL, Alouf JE, Berche P. Purification, characterization, and toxicity of the sulfhydryl-activated hemolysin listeriolysin O from Listeria monocytogenes. Infect Immun 1987; 55: 1641-1646.
20. Glomski IJ et al. The Listeria monocytogenes hemolysin has an acidic pH optimum to compartmentalize activity and prevent damage to infected host cells. J Cell Biol 2002; 156: 1029-1038.
21. Decatur AL, Portnoy DA. A PEST-like sequence in listeriolysin O essential for Listeria monocytogenes pathogenicity. Science 2000; 290: 992-995.
22. Dustin ML et al. Induction by IL 1 and interferon-gamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J Immunol 1986; 137: 245-254.
23. Goebeler M, Roth J, Kunz M, Sorg C. Expression of intercellular adhesion molecule-1 by murine macrophages is up-regulated during differentiation and inflammatory activation. Immunobiology 1993; 188: 159-171.
24. Springer TA. Adhesion receptors of the immune system. Nature 1990; 346: 425-434.
25. Katz SM et al. ICAM-1 antisense oligodeoxynucleotide improves islet allograft survival and function. Cell Transplant 2000; 9: 817-828.
26. Zeng Y et al. Inhibition of transplant rejection by pretreatment of xenogeneic pancreatic islet cells with anti-ICAM-1 antibodies. Transplantation 1994; 58: 681-689.
27. Zeng Y et al. Prolongation of human pancreatic islet xenografts by pretreatment of islets with anti-human ICAM-1 monoclonal antibody. Transplant Proc 1994; 26: 1120.
28. Bennett CF et al. Inhibition of endothelial cell adhesion molecule expression with antisense oligonucleotides. J Immunol 1994; 152: 3530-3539.
29. Stepkowski SM et al. Protection against allograft rejection with intercellular adhesion molecule-1 antisense oligodeoxynucleotides. Transplantation 1998; 66: 699-707.
30. Yacyshyn BR et al. A placebo-controlled trial of ICAM-1 antisense oligonucleotide in the treatment of Crohn's disease. Gastroenterology 1998; 114: 1133-1142.
31. Klimuk SK et al. Enhanced anti-inflammatory activity of a liposomal intercellular adhesion molecule-1 antisense oligodeoxynucleotide in an acute model of contact hypersensitivity. J Pharmacol Exp Ther 2000; 292: 480-488.
32. Beauregard KE, Lee KD, Collier RJ, Swanson JA. pH-dependent perforation of macrophage phagosomes by listeriolysin O from Listeria monocytogenes. J Exp Med 1997; 186: 1159-1163.
33. Anfossi G, Gewirtz AM, Calabretta B. An oligomer complementary to c-myb-encoded mRNA inhibits proliferation of human myeloid leukemia cell lines. Proc Natl Acad Sci USA 1989; 86: 3379-3383.
34. Glover JM et al. Phase I safety and pharmacokinetic profile of an intercellular adhesion molecule-1 antisense oligodeoxynucleotide (ISIS 2302). J Pharmacol Exp Ther 1997; 282: 1173-1180.
35. Butler M et al. Phosphorothioate oligodeoxynucleotides distribute similarly in class A scavenger receptor knockout and wild-type mice. J Pharmacol Exp Ther 2000; 292: 489-496.
36. Yu RZ et al. Pharmacokinetics and pharmacodynamics of an antisense phosphorothioate oligonucleotide targeting Fas mRNA in mice. J Pharmacol Exp Ther 2001; 296: 388-395.
37. Beltinger C et al. Binding, uptake, and intracellular trafficking of phosphorothioate-modified oligodeoxynucleotides. J Clin Invest 1995; 95: 1814-1823.
38. Straubinger RM, Duzgunes N, Papahadjopoulos D. pH-sensitive liposomes mediate cytoplasmic delivery of encapsulated macromolecules. FEBS Lett 1985; 179: 148-154.
39. Chiang MY et al. Antisense oligonucleotides inhibit intercellular adhesion molecule 1 expression by two distinct mechanisms. J Biol Chem 1991; 266: 18162-18171.
40. Monia BP, Johnston JF, Sasmor H, Cummins LL. Nuclease resistance and antisense activity of modified oligonucleotides targeted to Ha-ras. J Biol Chem 1996; 271: 14533-14540.
41. Higgins DE, Shastri N, Portnoy DA. Delivery of protein to the cytosol of macrophages using Escherichia coli K-12. Mol Microbiol 1999; 31: 1631-1641.
42. Harris RW, Sims PJ, Tweten RK. Kinetic aspects of the aggregation of Clostridium perfringens theta-toxin on erythrocyte membranes. A fluorescence energy transfer study. J Biol Chem 1991; 266: 6936-6941.
43. Henry SP et al. Evaluation of the toxicity of ISIS 2302, a phosphorothioate oligonucleotide, in a 4-week study in CD-1 mice. Antisense Nucleic Acid Drug Dev 1997; 7: 473-481.
44. Racoosin EL, Swanson JA. Macropinosome maturation and fusion with tubular lysosomes in macrophages. J Cell Biol 1993; 121: 1011-1020.